Unstable angina/ NSTEMI resident survival guide: Difference between revisions
Line 46: | Line 46: | ||
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}} | ❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}} | ||
{{familytree | |,|-|^|-|.| |!| | | | | | | |!| }} | {{familytree | |,|-|^|-|.| |!| | | | | | | |!| }} | ||
{{familytree | H01 | | H02 |!| | | | | | | |!| H01= NO | H02= ❑ heart faillure <br> ❑ serious arrhythmias ❑ subsequent isquemia}} | {{familytree | H01 | | H02 |!| | | | | | | |!| H01= NO | H02= ❑ heart faillure <br> ❑ serious arrhythmias <br> ❑ subsequent isquemia}} | ||
{{familytree | |!| | | |!| |!| | | | | |,|-|^|-|.| }} | {{familytree | |!| | | |!| |!| | | | | |,|-|^|-|.| }} | ||
{{familytree | I01 | | |!| |!| | | | | I02 | | I03 | | | I01= Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br> | {{familytree | I01 | | |!| |!| | | | | I02 | | I03 | | | I01= Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br> | ||
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas| | ❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas| | ||
I02= | I03= }} | I02= PCI <br> | ||
❑ Administer clopidogrel 24 hrs before <br> | |||
❑ As as possible in no bleeding risk patients who are unstable or with high risk of isquemia <br> | |||
❑ Administer UFH (50-100 units/kg) | |||
| I03= CABG <BR> | |||
❑ Continue aspirin + UFH <br> | |||
❑ Discontinue clopidogel 5 days before <br> | |||
❑ Discontinue enoxiparin and fondoparinaux 12-24 hrs before <br> | |||
❑ Discontinue IV GP inhibitors 4 hrs bfore <br> | |||
❑ Discontinue bivalirudin 3 hrs before }} | |||
{{familytree | | | | | | J01 | | | | | | | | | J01= INTENSIVE STRATEGY - ANGIOGRAPHY }} | {{familytree | | | | | | J01 | | | | | | | | | J01= INTENSIVE STRATEGY - ANGIOGRAPHY }} | ||
{{familytree | | | |,|-|-|^|-|-|.| | | | | | | }} | {{familytree | | | |,|-|-|^|-|-|.| | | | | | | }} | ||
Line 56: | Line 65: | ||
{{familytree | | | |!| | | |,|-|^|-|.| | | | }} | {{familytree | | | |!| | | |,|-|^|-|.| | | | }} | ||
{{familytree | | | L01 | | L02 | | L03 | | | L01= ❑ Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br> | {{familytree | | | L01 | | L02 | | L03 | | | L01= ❑ Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br> | ||
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas) | L02= | L03=}} | ❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas) | ||
| L02= PCI <br> | |||
❑ Administer clopidogrel 24 hrs before <br> | |||
❑ As as possible in no bleeding risk patients who are unstable or with high risk of isquemia <br> | |||
❑ Administer UFH (50-100 units/kg) | |||
| L03= CABG <BR> | |||
❑ Continue aspirin + UFH <br> | |||
❑ Discontinue clopidogel 5 days before <br> | |||
❑ Discontinue enoxiparin and fondoparinaux 12-24 hrs before <br> | |||
❑ Discontinue IV GP inhibitors 4 hrs bfore <br> | |||
❑ Discontinue bivalirudin 3 hrs before}} | |||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 17:18, 27 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Definition
Causes
Life Threatening Causes
Common Causes
Management
Diagnosis
Treatment
❑ Administer 300mg Aspirin immediately after hospital admission ❑ Administer oxygen in patients with saturation <90% | |||||||||||||||||||||||||||||||||||||||||
Determine Risk of adverse coronary event (TIMI) | |||||||||||||||||||||||||||||||||||||||||
LOW RISK Initial conservative strategy | HIGH RISK Initial invasive strategy | ||||||||||||||||||||||||||||||||||||||||
❑ Administer 300mg of copidogrel ❑ Administer fondoparinaux or UFH in case of renal failure | ❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban) OR ❑ Administer Bivalirudin | ||||||||||||||||||||||||||||||||||||||||
Perform a Stress test | Angiography | ||||||||||||||||||||||||||||||||||||||||
LOW RISK | HIGH RISK | NEGATIVE | POSITIVE | ||||||||||||||||||||||||||||||||||||||
Recurrent symptoms? | ❑ Continue Aspirin ❑ Continue with clopidrogel or ticagelor for 12 months ❑ Discontinue with GP inhibitors ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas) | ||||||||||||||||||||||||||||||||||||||||
NO | ❑ heart faillure ❑ serious arrhythmias ❑ subsequent isquemia | ||||||||||||||||||||||||||||||||||||||||
Continue Aspirin ❑ Continue with clopidrogel or ticagelor for 12 months ❑ Discontinue with GP inhibitors ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas | PCI ❑ Administer clopidogrel 24 hrs before | CABG ❑ Continue aspirin + UFH | |||||||||||||||||||||||||||||||||||||||
INTENSIVE STRATEGY - ANGIOGRAPHY | |||||||||||||||||||||||||||||||||||||||||
NEGATIVE | POSITIVE | ||||||||||||||||||||||||||||||||||||||||
❑ Continue Aspirin ❑ Continue with clopidrogel or ticagelor for 12 months ❑ Discontinue with GP inhibitors ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas) | PCI ❑ Administer clopidogrel 24 hrs before | CABG ❑ Continue aspirin + UFH | |||||||||||||||||||||||||||||||||||||||